Hello i look back to the france 24 newsroom. I am thomas waterhouse. The second american Drugs Company offers a fresh glimmer of hope with moderna saying its covid19 vaccine is 95 effective. The is trying to secure doses for the u. K. Who are already placing an owner. Order. Also, talking Recovery Plan. Frances zero minister is confident a solution can be found following the vetoes from the eastern Member States. And the u. S. President elect has on the bones of his economic vision. Joe biden says a new covid19 stimulus package needs to be quickly put together but he is also calling for a raise in the National Minimum wage. We will have more in our business update. It has been described by americans leading expert on Infectious Diseases as the light at the end of the tunnel. In the second time in recent days, the u. S. Drugs company has come forward to say that its experimental covid19 vaccine has been massively successful. Earlier this monday, moved during moderna inc. Says its trial
Moderna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 202,832 shares of Moderna stock in a transaction on Tuesday, June 11th. The shares were sold at an average price of $148.34, for a total transaction of $30,088,098.88. Following the completion of the sale, the director now directly owns 1,528,557 shares of the company’s […]
Moderna's makes money through the sale of biotech products, plus some grant and collaboration revenue. Its COVID-19 vaccine continues to drive revenues.
Humankind Investments LLC raised its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 32.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,636 shares of the company’s stock after buying an additional 1,882 shares during the period. Humankind Investments LLC’s holdings in […]
Moderna, Inc. (NASDAQ: MRNA) announced that it has submitted an application to the FDA seeking approval of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1, the latest variant of the novel virus responsible for the 2020 pandemic.